Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (278) Arrow Down
Filter Results: (278) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (393)
    • News  (76)
    • Research  (278)
    • Events  (9)
    • Multimedia  (1)
  • Faculty Publications  (138)

Show Results For

  • All HBS Web  (393)
    • News  (76)
    • Research  (278)
    • Events  (9)
    • Multimedia  (1)
  • Faculty Publications  (138)
← Page 9 of 278 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • 02 Jun 2011
  • Research & Ideas

Signing at the Top: The Key to Preventing Tax Fraud?

end of the tax form, after the form has been filled out and, consequently, after the potential cheating has occurred. (It's analogous to a witness first testifying in a court trial and then swearing on a Bible, "For the last twenty... View Details
Keywords: by Carmen Nobel; Accounting
  • 12 Jun 2018
  • First Look

New Research and Ideas, June 12, 2018

money using their mobile phones. Mobile money has grown quickly, but high stockout rates of currency persist due to suboptimal inventory decisions made by contracted employees (called agents). In partnership with a Tanzanian mobile money operator, we perform a View Details
Keywords: Dina Gerdeman
  • 12 May 2016
  • Research & Ideas

When Mass Shootings Lead to Looser Gun Restrictions

research, they defined a mass shooting as an incident in which four or more people, other than the shooter(s), are unlawfully fatally shot in a single incident not related to gangs, drugs, organized crime, or domestic disputes. “In other words, we focus on the types of... View Details
Keywords: by Carmen Nobel
  • 08 Dec 2003
  • Research & Ideas

Why Europe Lags in Pharmaceuticals and Biotech

the preferred testing ground for Phase 1 clinical trials of new drugs, the benefits of massive R&D spending and economic throw-offs are being enjoyed elsewhere, primarily in the United States and in an increasingly competitive Asia.... View Details
Keywords: by Sean Silverthorne; Biotechnology; Health; Pharmaceutical; Technology
  • 22 Apr 2014
  • First Look

First Look: April 22

Nava, Diego Aycinena, Claudia Martínez A., and Dean Yang Abstract—While remittance flows to developing countries are very large, it is unknown whether migrants desire more control over how remittances are used. This research uses a View Details
Keywords: Sean Silverthorne
  • 29 Aug 2006
  • First Look

First Look: August 29, 2006

the firm-size distribution; controlling for level of economic development, regulation, institutional constraints, and other variables that might affect the business environment; and using different empirical specifications. We further... View Details
Keywords: Sean Silverthorne
  • February 2013
  • Article

An Activity-Generating Theory of Regulation

By: Joshua Schwartzstein and Andrei Shleifer
We propose an activity-generating theory of regulation. When courts make errors, tort litigation becomes unpredictable and as such imposes risk on firms, thereby discouraging entry, innovation, and other socially desirable activity. When social returns to activity are... View Details
Keywords: Courts and Trials; Lawsuits and Litigation; Governing Rules, Regulations, and Reforms; Theory
Citation
Find at Harvard
Read Now
Purchase
Related
Schwartzstein, Joshua, and Andrei Shleifer. "An Activity-Generating Theory of Regulation." Journal of Law & Economics 56, no. 1 (February 2013): 1–38. (Lead Article.)
  • 14 May 2013
  • First Look

First Look: May 14

flexible random coefficients aggregate discrete choice model that accommodates heterogeneity in preferences for school quality and athletic success, and an extensive set of school fixed effects to control... View Details
Keywords: Sean Silverthorne
  • 30 Sep 2014
  • First Look

First Look: September 30

Experiment By: Cole, Shawn, Xavier Giné, and James Vickery Abstract—Weather is a key source of income risk, particularly in emerging market economies. This paper uses a randomized controlled View Details
Keywords: Sean Silverthorne
  • 21 Jul 2006
  • Op-Ed

Enron Jury Sent the Right Message

The most noteworthy message of the Enron trial is that corporate executives can be convicted in a court of law for a pattern of deception that may or may not be illegal. Left unaddressed in the trial were... View Details
Keywords: by Malcolm S. Salter
  • 30 Dec 2013
  • Research & Ideas

Most Popular Articles of 2013

alleviate congestion, and can actually increase it. Research by Jillian Berry Jaeker, Anita L. Tucker, and Michael H. Lee. Applying Random Coefficient Models to Strategy Research: Testing For Firm Heterogeneity, Predicting Firm-Specific... View Details
Keywords: by Staff
  • 17 Sep 2013
  • First Look

First Look: September 17

recommendations for stocks with larger market capitalizations and lower return volatility than their sell-side peers, consistent with their facing fewer conflicts of interest and having a preference for liquid stocks. Tests with no View Details
Keywords: Sean Silverthorne
  • 20 Sep 2011
  • First Look

First Look: September 20

likelihood that they will exploit their current exchange partners, even after controlling for the leverage provided by the outside options. Our results demonstrate that previously sunken investments lead to a heightened sense of... View Details
Keywords: Sean Silverthorne
  • 30 Jan 2012
  • Research & Ideas

Measuring the Efficacy of the World’s Managers

larger number of organizations. The researchers have also started to work on management experiments, modeled on the randomized control trials adopted in the medical field. This... View Details
Keywords: by Carmen Nobel
  • June 2023 (Revised July 2024)
  • Case

Biogen and the Aduhelm Melee

By: Amitabh Chandra and Lauren Gunasti
Alzheimer's Disease is a devastating condition affecting millions of Americans. At this time, there is no cure. In 2021, Biogen's Aduhelm (aducanumab) received FDA approval under the accelerated approval pathway after a controversial approval process.

This... View Details
Keywords: Health Testing and Trials; Governing Rules, Regulations, and Reforms; Valuation; Product Development; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Chandra, Amitabh, and Lauren Gunasti. "Biogen and the Aduhelm Melee." Harvard Business School Case 623-046, June 2023. (Revised July 2024.)
  • 10 Mar 2014
  • Research & Ideas

Counting Up the Effects of Sarbanes-Oxley

approach when considering SOX," explains Srinivasan. The most worrisome part of the act on the business side was the mandate that required public companies to obtain an independent audit of their internal control practices. The cost... View Details
Keywords: by Julia Hanna; Accounting; Banking
  • 21 Aug 2012
  • Research & Ideas

How to Sink a Startup

Tim Westergren of Pandora and Evan Williams of Twitter. YouTube cofounder and former CEO Chad Hurley has called the book "an invaluable alternative to real-world trial and error." A past recipient of the HBS student-voted award for... View Details
Keywords: by Garry Emmons
  • November 2009 (Revised March 2010)
  • Case

Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story

By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details
Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States
Citation
Educators
Purchase
Related
Hamermesh, Richard G., Raju Kucherlapati, and Rachel Gordon. "Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story." Harvard Business School Case 810-066, November 2009. (Revised March 2010.)
  • 09 Feb 2010
  • First Look

First Look: Feb. 9

both proprietary and shared platforms toward hybrid governance models characterized by centralized control over platform technology (i.e., closed sponsorship) and shared responsibility for serving users (i.e., an open provider role).... View Details
Keywords: Martha Lagace
  • 2010
  • Chapter

From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance

By: Arthur A. Daemmrich
Adverse drug reactions pose distinct but potentially catastrophic risks to patients, physicians, pharmaceutical firms, and regulators. Between the early 1960s and the present, national systems were built to collect, standardize, and respond to individual reports of... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Business and Government Relations; Risk and Uncertainty; Safety; Pharmaceutical Industry; United States
Citation
Find at Harvard
Related
Daemmrich, Arthur A. "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance." Chap. 13 in The Fragmentation of U.S. Health Care: Causes and Solutions, edited by Einer Elhauge, 301–322. Oxford: Oxford University Press, 2010.
  • ←
  • 9
  • 10
  • …
  • 13
  • 14
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.